These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 198124)

  • 1. Reduction of streptozotocin toxicity by 3-O-methyl-D-glucose with enhancement of antitumor activity in murine L1210 leukemia.
    Wick MM; Rossini A; Glynn D
    Cancer Res; 1977 Nov; 37(11):3901-3. PubMed ID: 198124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic beta cell toxicity by streptozotocin anomers.
    Rossini AA; Like AA; Dulin WE; Cahill GF
    Diabetes; 1977 Dec; 26(12):1120-4. PubMed ID: 145386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of streptozotocin-induced insulitis and diabetes.
    Rossini AA; Like AA; Chick WL; Appel MC; Cahill GF
    Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2485-9. PubMed ID: 142253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical effects and therapeutic potential of tunicamycin in murine L1210 leukemia.
    Morin MJ; Bernacki RJ
    Cancer Res; 1983 Apr; 43(4):1669-74. PubMed ID: 6339042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonglycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy.
    Hwang YY; Kim SG; Evelhoch JL; Ackerman JJ
    Cancer Res; 1992 Mar; 52(5):1259-66. PubMed ID: 1737388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
    Woodman RJ; Cysyk RL; Kline I; Gang M; Venditti JM
    Cancer Chemother Rep; 1975; 59(4):689-95. PubMed ID: 1175163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
    Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
    Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of streptozotocin-induced insulitis and hyperglycaemia in the mouse.
    Sandler S; Andersson A
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):93-8. PubMed ID: 3157292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pretreatment with alpha-difluoromethylornithine on the selectivity of methylglyoxal bis(guanylhydrazone) for tumor tissue in L1210 leukemic mice.
    Kramer DL; Paul B; Porter CW
    Cancer Res; 1985 Jun; 45(6):2512-5. PubMed ID: 3921245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of streptozotocin-induced alterations in the rat heart by 3-O-methyl glucose and insulin treatments.
    Ramanadham S; Young J; Tenner TE
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):291-7. PubMed ID: 2437395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorozotocin, 2-(3-(2-chloroethyl)-3-nitrosoureido)-D-glucopyranose, an antitumor agent with modified bone marrow toxicity.
    Anderson T; McMenamin MG; Schein PS
    Cancer Res; 1975 Mar; 35(3):761-5. PubMed ID: 123170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimum dose of nicotinamide for protection of pancreatic beta-cells against the cytotoxic effect of streptozotocin in albino rat.
    Hassan N; Janjua MZ
    J Ayub Med Coll Abbottabad; 2001; 13(3):26-30. PubMed ID: 11873395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-methyl-1-nitrosourea and dialkylnitrosamine depression of nicotinamide adenine dinucleotide.
    Schein PS
    Cancer Res; 1969 Jun; 29(6):1226-32. PubMed ID: 4307783
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
    Sirotnak FM; Poser RE; Barrueco JR
    Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and B-cell function of mouse pancreatic islets maintained in culture after concomitant exposure to streptozotocin and nicotinamide.
    Strandell E; Eizirik DL; Sandler S
    Exp Clin Endocrinol; 1989 May; 93(2-3):219-24. PubMed ID: 2528468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorozotocin. Mechanism of reduced bone marrow toxicity in mice.
    Panasci LC; Green D; Schein PS
    J Clin Invest; 1979 Oct; 64(4):1103-11. PubMed ID: 158033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.